AI English summary of an SEC filing — figures as filed
Synopsys said it received a letter from the U.S. Department of Commerce's Bureau of Industry and Security (BIS) on May 29, 2025 informing it of new China-related export restrictions. The letter came after the company announced its financial results for the Q2 quarter ended April 30, 2025 (BIS Letter).
Key points
AI summarySynopsys said it received a letter from the U.S. Department of Commerce's Bureau of Industry and Security (BIS) on May 29, 2025 informing it of new China-related export restrictions. The letter came after the company announced its financial results for the Q2 quarter ended April 30, 2025 (BIS Letter).
The company said that, in connection with the BIS Letter, it suspended its financial guidance for the Q3 of fiscal 2025 and for full-year fiscal 2025.
Synopsys said it is currently assessing the potential impact of the BIS Letter on its business, operating results and financial condition.
Synopsys said the information in Item 7.01 is not deemed filed under Section 18 of the Securities Exchange Act and is not incorporated by reference into other registration statements or filings. It said the information is as of May 29, 2025 and that it does not intend to update forward-looking statements unless required by law.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Synopsys receives BIS letter on China export curbs
Synopsys said it received a letter from the U.S. Department of Commerce's Bureau of Industry and Security (BIS) on May 29, 2025 informing it of new China-related export restrictions. The letter came after the company announced its financial results for the Q2 quarter ended April 30, 2025 (BIS Letter).
Source · Based on the filing body and exhibits
Synopsys suspends Q3 and full-year outlook
The company said that, in connection with the BIS Letter, it suspended its financial guidance for the Q3 of fiscal 2025 and for full-year fiscal 2025.
Source · Based on the filing body and exhibits
Synopsys assessing BIS Letter impact
Synopsys said it is currently assessing the potential impact of the BIS Letter on its business, operating results and financial condition.
Source · Based on the filing body and exhibits
Nature of Item 7.01 information filing
Synopsys said the information in Item 7.01 is not deemed filed under Section 18 of the Securities Exchange Act and is not incorporated by reference into other registration statements or filings. It said the information is as of May 29, 2025 and that it does not intend to update forward-looking statements unless required by law.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…